Samuel Valable

17PUBLICATIONS
46CO-AUTHORS
Instruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyMolecular targetsNanomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jul 28, 2026
Multi-assay profiling of blood lymphocytes radiosensitivity under protons or photons.

|May 02, 2026
Fenofibrate as an anti-cancer treatment: an in vitro study on glioblastoma cells at various oxygen levels and on normal astrocytes.

|Mar 28, 2026
Evaluation of a Boron-Conjugated SRC Inhibitor Combined with Proton and X-Ray Irradiation in U-87 MG and U-87 MG IDH1R132H Glioma Cell Lines.

Cristiana Alberghina, Filippo Torrisi, Samuel Valable

|Dec 18, 2025
Longitudinal prediction of T and B lymphocyte kinetics following brain irradiation in rodents.

Thao-Nguyen Pham, Julie Coupey, Florian Yger

|Oct 21, 2025
Tumor Site-Specific Radiation-Induced Lymphocyte Depletion Models After Fractionated Radiotherapy: Considerations of Model Structure From an Aggregate Data Meta-Analysis.

Thao-Nguyen Pham, Julie Coupey, Samuel Valable

|Sep 19, 2025
Manganese (III) tetrakis (4-benzoic acid) porphyrin (MnTBAP) represses sulfide:quinone oxidoreductase expression and targets the sulfido-redox system in glioblastoma models.

Elise Malard, Benoît Bernay, Jérôme Toutain

Pageof 3

Frequent Collaborators

6 joint publications

Juliette Thariat

4 joint publications

Rosalba Parenti

3 joint publications

Nunzio Vicario

3 joint publications

Thao-Nguyen Pham